Tag Archives: Surgery and Neurotechnology

Neurotech Reports Announces Thomas Stieglitz, Ph.D., as Keynote Speaker for the Second Annual Neurotech Leaders Forum imec

SAN FRANCISCO, Calif., May 14, 2026 (SEND2PRESS NEWSWIRE) — Neurotech Reports today announced that Thomas Stieglitz, Ph.D., a globally recognized expert in neural engineering and implantable neurotechnology, will keynote the Second Annual Neurotech Leaders Forum imec, taking place June 23-24, 2026, in Leuven, Belgium.

Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec.

The Neurotech Leaders Forum brings together senior executives, investors, researchers, clinicians, and technology developers working at the forefront of neurotechnology, bioelectronic medicine, and brain-computer interface innovation. The event serves as a platform for examining emerging technologies, commercialization trends, investment activity, and the evolving direction of the neurotech industry across Europe and internationally.

“Dr. Thomas Stieglitz represents the kind of visionary leadership that continues to drive the neurotechnology field forward,” said James Cavuoto, editor and publisher of Neurotech Reports. “His perspective on the convergence of engineering, neuroscience, and clinical application will provide tremendous value for attendees from across the neurotech ecosystem.”

“Advances in neural interfaces and bioelectronic medicine are creating entirely new possibilities for treating neurological disorders and restoring function,” said Dr. Stieglitz. “I am honored to participate in this year’s Neurotech Leaders Forum imec and contribute to the conversation about the future of neurotechnology.”

Dr. Stieglitz is widely recognized for his contributions to neural interface technologies and implantable systems aimed at restoring and modulating nervous system function. Throughout his career, he has combined academic leadership with entrepreneurial innovation, co-founding companies focused on neural implants and neuromodulation therapies. He has authored more than 200 scientific journal articles, contributed extensively to conference literature, and is named on dozens of patents spanning neurotechnology and biomedical engineering.

Launched in 2025, the Neurotech Leaders Forum imec has quickly become a key meeting point for neurotechnology executives, researchers, and investors from across Europe and North America. The 2026 Forum will bring together leaders in neurostimulation, brain-computer technologies, implantable devices, AI-enabled neurotechnology, and investment at imec, one of Europe’s leading research and innovation centers.

Additional information and registration details are available at: https://www.neurotechreports.com/pages/leadersforum-europe.html

More information about imec is available at: https://www.imec-int.com/

ABOUT NEUROTECH REPORTS

Neurotech Reports, part of Cambridge Innovation Institute, is a leading source of market research, industry analysis, and business news covering neurotechnology, neuromodulation, and bioelectronic medicine. Through its publications and executive conferences, the company provides insights into emerging technologies, commercial trends, and investment activity shaping the global neurotech industry. Learn more: https://www.neurotechreports.com/

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/26-0514-s2p-stieglitz-300dpi.webp

Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec

LOGO: https://www.neurotechreports.com/images/nlf-imecFlag-horiz.png

NEWS SOURCE: Neurotech Reports

This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/neurotech-reports-announces-thomas-stieglitz-ph-d-as-keynote-speaker-for-the-second-annual-neurotech-leaders-forum-imec/

Iota Biosciences Founder to Keynote 2026 Bioelectronic Medicine Forum in NYC

European firms Coherence Neuro and Graphenicalab will present at the meeting, as will U.S. startup firm Spiro Medical

NEW YORK, N.Y., March 5, 2026 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Ninth Annual Bioelectronic Medicine Forum will take place on April 14, 2026. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Photo caption: iota Biosciences CEO Michel Maharbiz will keynote the 2026 Bioelectronic Medicine Forum in New York City on April 14.

Michel Maharbiz, CEO of iota Biosciences, will keynote the conference. The innovative bioelectronic medicine firm spun off from UC Berkeley in 2017 and was acquired by Astellas, a global pharmaceutical company, in 2021 in a deal worth several hundred million dollars. Until 2021, Michel was a full professor and is now an adjunct professor with the department of electrical engineering and computer science at the University of California, Berkeley. Prof. Maharbiz received his B.S. from Cornell University and his Ph.D. from the University of California, Berkeley under nanotechnologist Prof. Roger T. Howe and synthetic biologist Jay D. Keasling.

European firms Coherence Neuro and Graphenicalab will present at the meeting, as will U.S. startup firm Spiro Medical. Venture capital professionals Jeff Chu from Features Capital, Allan Gobbs from ATEM Capital, and Jeffrey Scott Cohen from Ladenburg Thalmann & Co will participate in panels devoted to investment in bioelectronic medicine.

There will also be several informative panel discussions on key topics such as novel diagnostics, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, Victor Pikov, and JoJo Platt will moderate sessions at the event.

Also at the event, Jennifer French, executive director of Neurotech Network, will sit down for a fireside chat with Neurotech Reports editor James Cavuoto for a discussion on the history of the bioelectronic medicine industry.

Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor. Osypka is the Silver Sponsor.

“Bioelectronic medicine merges some of the best attributes of biopharma and neurotech approaches to treating systemic disorders,” said James Cavuoto, editor and publisher at Neurotech Reports. “This ninth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry.”

For more information on the 2026 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

MULTIMEDIA

Photo link for media: https://www.Send2Press.com/300dpi/26-0305-s2p-Maharbiz-300dpi.webp

Photo caption: iota Biosciences CEO Michel Maharbiz will keynote the 2026 Bioelectronic Medicine Forum in New York City on April 14.

LOGO links:

[1] https://neurotechreports.com/images/bmflogo.jpg

[2] https://www.neurotechreports.com//images/neurotech_business_SimpleBug.png

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/iota-biosciences-founder-to-keynote-2026-bioelectronic-medicine-forum-in-nyc/

Two Prominent Professors to Keynote 25th Annual Neurotech Leaders Forum

SAN FRANCISCO, Calif., Aug. 11, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that two prominent figures in the field of neurotechnology will keynote the 2025 Neurotech Leaders Forum, which takes place November 5-6 in San Francisco. Edward Chang, chair of the department of neurological surgery at UC San Francisco, will discuss future applications of implanted brain sensing and stimulation devices.

Image caption: Prof. Edward Chang, M.D., from UC San Francisco (L) and J. Thomas Mortimer, Ph.D., Emeritus from Case Western University (R) will keynote the 2025 Neurotech Leaders Forum in San Francisco.

J. Thomas Mortimer, emeritus professor of biomedical engineering at Case Western Reserve University, will discuss his history as a pioneer developing implanted neurostimulation systems for chronic pain, diaphragm pacing, and bladder control.

The 25th annual event will also feature sessions devoted to the business of neuromodulation, the investment outlook for neurotechnology, the convergence of AI and BCI technologies, new realities in regulatory and reimbursement policies, and several other topics. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate panel discussions with key industry leaders.

Several panelists and presenters were recently added to the agenda for the two-day conference. New speakers include Ryan Field, CEO of Kernel; Andreas Forland, CEO of Cognixion; and Oliver Armitage, newly appointed vice president of Axoft. Venture capital professionals participating in the meeting include Mir Imran, managing partner at InCube Ventures, and Lu Zhang, founder and managing partner of Fusion Fund.

Among the new presenters this year are Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain and Tetiana Aleksandrova, CEO of Subsense, Inc., which is developing a nonsurgical nanoparticle-based BCI system.

The Platinum Sponsor at this year’s event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Silver sponsors include Velentium and Valtronic.

“As we celebrate our 25th year covering the neurotechnology industry, it’s gratifying to have Prof. Mortimer, one of the founders of the field, and Prof. Chang, one of the most promising researchers and entrepreneurs, talk about the past and future of our industry,” said James Cavuoto, editor and publisher of Neurotech Reports.

Neurotech Reports has extended the early-bird registration deadline until September 12, 2025.

Also, Neurotech Reports still has openings for a small number of startup and early-stage firms who would like to present during one of two Entrepreneur Panels at the conference.

To apply, visit this link: https://www.neurotechreports.com/pages/nlf-presenter-application.html

For more information, contact Neurotech Reports at 415 546 1259 or visit https://www.neurotechreports.com/.

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0811-s2p-ntpchangmortimer-300dpi.jpg

Neurotech Reports logo: https://www.neurotechreports.com//images/neurotech_business_SimpleBug.png

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/two-prominent-professors-to-keynote-25th-annual-neurotech-leaders-forum/

Biogen VP to Keynote 2025 Bioelectronic Medicine Forum in NYC

NEW YORK, N.Y., March 17, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual Bioelectronic Medicine Forum will take place on April 10, 2025. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine Forum in New York City on April 10.

Lisa Shafer, a vice president at biotech firm Biogen, will keynote the conference. Shafer has held executive management positions at key pharmaceutical firms such as Teva as well as neurotech firms such as Medtronic. In her distinguished career, she has helped bridge the gap between device and drug therapies as a chief scientific officer and product development executive. She earned her Ph.D. in neuroscience and neuroimmunology from Loyola University.

German firm Precisis, OSA startup LunOSA, European neuroprosthetics firm ReVision, and focused ultrasound firm Sanmai will present for the first time at the meeting. Also presenting will be executives from NeuroSigma, ANEUVO, and Synergia Medical. Venture capital professionals Jeff Chu from Features Capital, Mir Imran from InCube Ventures, and Jeffrey Scott Cohen from Ladenburg Thalmann & Co will participate in a session moderated by JoJo Platt devoted to investment in bioelectronic medicine.

Contributing editor Victor Pikov will moderate a session with executives from three firms in the neuromodulation space for treating obstructive sleep apnea, including market leader Inspire Medical Systems, and challengers Nyxoah and LivaNova.

There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, and JoJo Platt will moderate sessions at the event.

Also at the event, former Axonics CEO Ray Cohen will sit down for a fireside chat with Neurotech Reports Senior Consulting Editor Jeremy Koff for a discussion on the bowel and bladder neuromodulation market.

Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor. Osypka and Black Swan IP are Bronze Sponsors.

“Bioelectronic medicine merges some of the best attributes of biopharma and neurotech approaches to treating systemic disorders,” said James Cavuoto, editor and publisher at Neurotech Reports. “This eighth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry.”

For more information on the 2025 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

IMAGE link for media: https://www.Send2Press.com/300dpi/25-0317-s2p-LisaShafer-300dpi.jpg

Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine Forum in New York City on April 10.

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/biogen-vp-to-keynote-2025-bioelectronic-medicine-forum-in-nyc/

Neurotech Reports Announces First European Leaders Forum

SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference.

Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium.

Tim Denison, Ph.D. FREng, co-founder of Amber Therapeutics, will keynote the conference. Denison also holds a joint appointment in engineering science and clinical neurosciences at Oxford University, where he explores the fundamentals of physiologic closed-loop systems. Prior to that, he was a technical fellow at Medtronic plc and vice president of research & core technology for the Restorative Therapies Group, where he helped oversee the design of next generation neural interface and algorithm technologies for the treatment of chronic neurological disease.

At the conference, Neurotech Reports editor James Cavuoto will offer an update on the state of the European neuromodulation industry. Neurotech Reports editors JoJo Platt, Jeremy Koff, and Victor Pikov will moderate sessions devoted to peripheral nerve stimulation, bioelectronic medicine applications, venture capital investment, and regulatory and reimbursement issues affecting neurotech startups and emerging firms. Imec executives Peter Peumans, Paru Deshpande, and Barun Dutta (who conceived of, and led the Neuropixels program at imec since its inception) will also offer updates on technology advances at the European research and innovation center.

Executives from several emerging neurotechnology startups, including Italian firm WISE srl and German firm Precisis, will also present at the conference during multiple entrepreneur panels. In addition to imec, sponsors of the conference include Cirtec Medical, MST, Valtronic, and Osypka.

Neurotech Reports will also produce the 8th Annual Bioelectronic Medicine Forum on April 10, 2025 in New York City, and the 25th Annual Neurotech Leaders Forum San Francisco, on November 5-6, 2025.

For more information, contact Neurotech Reports at 415 546 1259 or visit: https://neurotechreports.com/pages/leadersforum-europe.html.

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0130-s2p-ntrep-timdenison-300dpi.jpg

Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium.

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/neurotech-reports-announces-first-european-leaders-forum/

IEP Careers and IEP Physician Search Secure Partnership with ISASS to Assist Placing Spine Surgeons

SAN DIEGO, Calif., Nov. 11, 2024 (SEND2PRESS NEWSWIRE) — The International Society for the Advancement of Spine Surgery (ISASS) has teamed up with Magnifi Group, Inc. to assist its surgeon members in securing their next career opportunity. This partnership gives ISASS surgeon members access to both the IEP Careers Job Board and the IEP Physician Search Solutions.

Image caption: IEP Physician Search.

The IEP Careers Job Board will be accessible directly through the ISASS website. It features the most recent available spine surgeon positions and allows ISASS Members to set up their profiles, post their resumes, and receive real-time job alerts.

ISASS members’ practices can easily post their open positions, ensuring exposure to qualified candidates across the U.S.

This partnership positions IEP Careers to become the leading job board for spine surgeons. Magnifi has an extensive database of spine surgeons and network of medical centers through its 14 years of hosting the Spine IEP Fellows and Young Surgeons Course – www.spine-iep.com. “Each year, our course helps us build relationships with the next generation of spine surgeons,” said Andrew Wolpe, President & COO of Magnifi Group. Wolpe added that this helps IEP Careers feature the latest available spine jobs and surgeon candidates.

IEP Physician Search – a Magnifi Group partner company – is a full-service recruiting solution that specializes in helping spine surgeons find their perfect practice. This service will be available at no cost to ISASS members.

Liesl Bernard, CEO of IEP Physician Search, said her team has a deep understanding of the requirements and the unique needs of both candidates and medical practices. “IEP Physician Search will take the required time to meet the specific goals and preferences of all candidates and medical centers, ensuring the right fit,” Bernard said. Bernard added that IEP Physician Search does not charge a retainer and is only paid on successful candidate placement.

Rick Thiele, Executive Director of ISASS, said IEP Careers and IEP Physician Search are natural extensions of the organization’s role in providing a comprehensive platform to its members. “Teaming up with IEP Careers and IEP Search will significantly assist both new and seasoned ISASS members who are looking to make a change,” Thiele said.

Founded in 2000, ISASS is committed to enhancing the science and practice of non-operative and surgical interventions to restore and improve function to the spine. In keeping with the rapidly developing aspects of spine care, ISASS serves as a platform for the exchange of experience, ideas, and evidence regarding technologies, procedures, and modalities for the diagnosis and treatment of spinal conditions. ISASS will hold its 25th Annual Conference, April 10-12, 2025, in Miami, FL. Learn more: https://isass25.eventscribe.net/

IEP Careers and IEP Search are dedicated to connecting exceptional orthopedic and neuro spine surgeons with premier healthcare facilities across the United States. Learn more: www.iep-careers.com and https://iep-search.com/.

For additional information, contact Talia Guliasi. tguliasi@magnifigroup.com

LOGO link for media: https://iep-search.com/wp-content/uploads/2023/06/IEP-Logo-web.jpg

NEWS SOURCE: Magnifi Group

This press release was issued on behalf of the news source (Magnifi Group), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/iep-careers-and-iep-physician-search-secure-partnership-with-isass-to-assist-placing-spine-surgeons/

Promising Neurotechnology Startups to Present at the 24th Neurotech Leaders Forum

SAN FRANCISCO, Calif., Oct. 15, 2024 (SEND2PRESS NEWSWIRE) — Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forum in San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention.

Image caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum.

Also presenting for the first time will be Katya Sverdlov, CEO and co-founder of JelikaLite, a clinical stage medtech company focused on the treatment of autism. Another new presenter is Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain.

Other entrepreneur presenters at this year’s conference include Emily Mirro, President of SynchNeuro Inc., Andy Gotshalk, CEO, Neurologic Solutions, Luca Ravagnan, CEO of Italian firm WISE srl, Kial Gramley of BackStop Neural, and Imanuel Lerman, CEO, InflammaSense, Inc.

Raymond Cohen, CEO of Axonics Inc., will keynote the 24th annual event—the most established in the industry. Mr. Cohen has served as CEO and member of the board of directors of Axonics since co-founding the company in October 2013. Axonics recently announced it would be acquired by Boston Scientific in a $3.7 billion deal.

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled “BCI Frenzy: Separating the Facts from the Hype in the Brain Implant Market,” which will feature executives from several BCI firms. Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled “Market Share Battles: Neuromodulation’s Competitive Outlook.” Neurotech Reports editor James Cavuoto will moderate a session titled “Looking for the Exit: Investors Exploit Renewed Interest in Neurotech,” which will feature a discussion with key VC professionals. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled “Biomarking Your Territory: Neurosensing Technologies Enhance Closed-Loop Neuromodulation.”

Platinum Sponsor at this year’s event is Cirtec Medical. MST is Gold Sponsor. Valtronic, Velentium, and Neo-Bionica are Silver Sponsors, while TTP, Osypka, Corundum Neuroscience, Focus, and CorTec are Bronze Sponsors.

For more information, contact Neurotech Reports at 415 546 1259 or visit: http://neurotechreports.com/pages/leadersforum.html.

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/24-1015-s2p-ray-cohen-300dpi.jpg

Caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum in San Francisco, November 6-7, 2024.

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/promising-neurotechnology-startups-to-present-at-the-24th-neurotech-leaders-forum/

Magnifi Group Teams up with Kalon Staffing to Launch IEP Physician Search – Specifically Targeting Fellows

SAN DIEGO, Calif. /ScoopCloud/ -- Magnifi Group, Inc. and Kalon Staffing, LLC, today announced the launch of IEP Physician Search - iep-search.com - a Fellows search service to place Orthopaedic, Pain Management and Electrophysiology (EP) Fellows in US Medical Centers.

Magnifi Group is uniquely positioned to ensure IEP Physician Search's success due to the didactic courses it holds for Fellows in numerous Orthopaedic specialties, Pain Management and Electrophysiology.

Teaming up with Kalon will further accelerate the accomplishments of IEP Physician Search due to the company's extensive experience placing proven specialists into highly skilled positions.

Andrew Wolpe, president and COO of Magnifi Group said demand from Medical Practices for Fellows entering their respective fields is significantly high due to the relatively small number that are available each year. "We're looking at an average of only 100 Fellows per specialty, per year," said Wolpe. "Since we meet them at our IEP Courses, it's a natural next step to assist these Fellows in their career placement," Wolpe said.

Liesl Bernard, CEO of Kalon Staffing, said her team assesses the criteria for all Fellows has when placing them. "For some, it's geography, for others it's the size of practice and of course it comes down to chemistry," Bernard said. Bernard added that she and her team play a critical role in working with both the medical centers and the Fellows to ensure the perfect match.

Magnifi Group, Inc. is a developer of an FDA-compliant eLearning platform for the medical device and biologics industries. The company also hosts the Spine IEP Live Fellows Course; the Lower Extremity IEP Live Fellows Course; the Hip and Knee IEP Live Fellows Course; the Electrophysiology IEP Live Fellows Course and the Pain Management IEP Live Fellows Course.

Kalon Staffing, LLC. is an executive search firm focused on making precision placements in specialized health and medical fields.

Learn more: http://iep-search.com/

Magnifi Group, Inc. and Kalon Staffing, LLC, today announced the launch of IEP Physician Search - iep-search.com - a Fellows search service to place Orthopaedic, Pain Management and Electrophysiology (EP) Fellows in US Medical Centers.

Related link: https://www.magnifigroup.com/

Tom Oxley to Keynote the 2024 Bioelectronic Medicine Forum in New York City

NEW YORK, N.Y. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Seventh Annual Bioelectronic Medicine Forum will take place on April 5, 2024. The one-day event will be held at the New York Academy of Medicine in Manhattan.

The keynote speaker at this year's event is Tom Oxley, CEO of Synchron and an interventional neurologist at Mount Sinai Health System. Synchron's internationally acclaimed stentrode device can record brain activity from within a blood vessel. In the intended application of the technology, the user's thoughts are captured, decoded and passed wirelessly through the skin to enable control of digital devices that enable movement and speech restoration to previously paralyzed patients.

Executives and entrepreneurs from several early stage and startup bioelectronic medicine firms will make presentations at the conference. Among these are Sinaptica Therapeutics, Neurosoft Bioelectronics, Helius Medical, PathMaker Neurosystems, Five Liters, Nia Therapeutics, Backstop Neural, WISE srl, and NeuroSigma.

There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate sessions at the event. A panel on investment will feature Diana Saraceni, General Partner at Panakes Partners, David Neustaedter, Venture Partner at Deerfield, and others.

Cirtec Medical is the Platinum Sponsor of the conference. MCRA is the Silver Sponsor and CorTec is the Bronze Sponsor.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This seventh-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry."

For more information on the 2024 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

RELATED LINKS:
https://www.synchron.com/
https://cirtecmed.com/
https://www.mcra.com/
https://www.cortec-neuro.com/

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Seventh Annual Bioelectronic Medicine Forum will take place on April 5, 2024. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Related link: https://www.neurotechreports.com/

Emerging Neurotechnology Startups to Present at 2023 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Among the new and emerging neurotech firms presenting at the conference are Opto Biosystems, a U.K. developer of novel diagnostics for brain cancer, NeuraLace Medical, a San Diego-based manufacturer of noninvasive therapies for treating chronic pain, Spark Biomedical, a Texas firm developing noninvasive therapies for treating addiction, and Harmonic Pain Solutions, an Atlanta, GA-area developer of wearable pain devices that use mechanical stimulation.

Jim Schuermann, president and CEO of Saluda Medical, will deliver the keynote address on the morning of November 6. He will speak on the topic "New Directions in Neuromodulation."

Daniel Kraft, founder of NextMed Health, chair of medicine for Singularity University, and chair of the XPrize Pandemic & Health Alliance, will deliver a keynote address on November 7 devoted to the topic, "The Future of Health and Medicine: Where Can Technology Take Us?" Kraft is board certified in internal medicine and pediatrics and completed fellowships in hematology/oncology and bone marrow transplantation at Stanford. He has given six TED & TEDMED talks.

Another featured presenter will be Prasad Shirvalkar, an associate professor at UC San Francisco School of Medicine, who recently co-authored a seminal paper relating to pain biomarkers. Chris Rozell, a professor at Georgia Tech, who recently coauthored a paper on biomarkers for depression, will also make a presentation at the event.

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled "Neurotech Investment: Bouncing Back from the Downturn," which will feature advice and recommendations from several venture capital professionals, including Sara Shnider from Joy Ventures, Martin Dieck from Neurotechnology Investors, and Suraj Mudichintala from Action Potential Venture Capital.

Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled "Changing Landscape: New SCS and PNS Vendors Enter the Scene," which will examine the current competitive environment in neuromodulation. Neurotech Reports editor James Cavuoto will moderate a session titled "Interpreting the Data: Neuromodulation Vendors Ward Off Negative Publications. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled "Choosing Our Role Models: What Neurotech Can Learn from Other Healthcare Industries."

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic, Velentium, Focus, Neo-Bionica, and Iris Biomedical are Silver Sponsors, while TTP and Microdul are Bronze sponsors.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: https://www.neurotechreports.com/

Spine IEP Fellows & Young Surgeons’ Course Announces Premier Foundation Sponsor for its 2023 Course

SAN DIEGO, Calif. /ScoopCloud/ -- Magnifi Group, Inc., announced today its partnership with SI-BONE, Inc. as the Premier Foundation Sponsor for its 2023 Spine IEP Fellows & Young Surgeons' Course to be held in Atlanta, Georgia, November 17-19.

SI-BONE is a global leader in technology for the surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 3,000 surgeons in performing a total of over 80,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including two randomized controlled trials and over 120 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.

As a returning sponsor to the Spine IEP Course, SI-BONE is committed to advancing the field of spine surgery through innovation, education, and collaboration with leading medical professionals.

Geoff Maw, SI-BONE Vice President of US Academic & Commercial Development said SI-BONE has a long history of dedicating time and resources to the next generation of spine surgeons.

"The Spine IEP Fellows & Young Surgeons' Course is an ideal setting in which SI-BONE can further support the education of young surgeons," Maw said. "We look forward to taking a leading role in our commitment to this important course," Maw added.

"The Spine IEP Course for Fellows & Young Surgeons, now in its 13th consecutive year, continues to educate attendees on the latest medical device techniques and biologics," said Dr. Frank Phillips, Spine IEP Course Chair and Director, Department of Orthopedic Surgery, Rush University Medical Center. "SI Bone has been an active participant at the Spine IEP Course for many years and we welcome the company's sustained commitment to Spine Fellows & Young Surgeons," Phillips said.

The Spine IEP Fellows & Young Surgeons' Course, is limited to 50-55 attendees in order to accommodate a didactics rotation schedule of 45-50 tables hosted by medical device and biologics companies. Four cadaver labs will also be offered during the duration of the course.

The interactive course has been specifically developed to educate spine and neurosurgery Fellows and Young Surgeons on current topics related to the practice of spine and neurosurgery, as well as to assist attendees with the transition from academics to practicing surgeons. The classroom format for the course is highly interactive and all sessions conclude with question/answer sessions and panel discussions.

According to Magnifi data, an average of 70-80 spine Fellows enter the US market each year as practicing spine surgeons. Of these, 48-50 Fellows & Young Surgeons are expected to attend the upcoming course.

Magnifi Group, Inc. is a developer of an FDA-compliant eLearning platform for the medical device and biologics industries. The company also hosts the Spine IEP Live Fellows Course; the Lower Extremity IEP Live Fellows Course and the Hip and Knee IEP Live Fellows Course.

Learn more: https://www.magnifigroup.com/

Magnifi Group, Inc., announced today its partnership with SI-BONE, Inc. as the Premier Foundation Sponsor for its 2023 Spine IEP Fellows & Young Surgeons' Course to be held in Atlanta, Georgia, November 17-19. SI-BONE is a global leader in technology for the surgical treatment of musculoskeletal disorders of the sacropelvic anatomy.

Related link: https://www.magnifigroup.com/

Helen Mayberg to Keynote 2023 Bioelectronic Medicine Forum in New York City

NEW YORK, N.Y. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Sixth Annual Bioelectronic Medicine Forum will take place on April 4, 2023. The one-day event will be held at the New York Academy of Medicine in Manhattan.

The keynote speaker at this year's event is Helen Mayberg, Director of the Nash Family Center for Advanced Circuit Therapeutics at Mount Sinai School of Medicine. Mayberg is recognized as one of the pioneers of neuromodulation for treating psychiatric disorders. She will speak on the topic, "Pharmacological therapies simply aren't enough."

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate sessions at the event

The founders and CEOs of several promising bioelectronic medicine startups will also present at the conference. Entrepreneur presenters Brad Schmidt, CEO of Panaxium, which is developing a new "iontronic" brain interface, Marc Powell, CEO of Reach Neuro, which has developed a new stroke rehabilitation therapy, Luca Ravagnan, CEO of WISE srl, an Italian firm developing thin, stretchable brain electrodes, and Karen Crow, CEO of NeuroGeneces, which has developed a sleepband that performs brain health assessment using A.I. and EEG data.

Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor and Valtronic and Velentium are Silver Sponsors.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This sixth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry."

For more information on the 2023 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Sixth Annual Bioelectronic Medicine Forum will take place on April 4, 2023. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Related link: https://www.neurotechreports.com/

Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Mudit Jain, Ph.D., general partner at VC firm Treo Ventures, will keynote the conference. Dr. Jain has more than two decades of medical device industry experience across company formation, R&D, business development, and venture capital, with a global perspective on healthcare based on his experiences in the U.S., Ireland, and India. He is the co-founder of NuXcel, a medical device accelerator, and also serves as chairman of the board of ShiraTronics Inc., a NuXcel spinoff. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

"The neurotechnology industry has emerged as one of the most promising areas of healthcare technology, and Neurotech Reports has been following the space longer than any other organization," said James Cavuoto, editor and publisher at Neurotech Reports. "This year's conference-our 22nd annual-will offer unique insights for management and investment professionals involved with the industry."

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to reimbursement, securing funding, the new competitive landscape in neuromodulation, deep-brain stimulation, and neurorehabilitation. New this year is a session devoted to privacy, security, and ethics in neurotechnology.

Among the companies presenting this year are gBrain, a Korean manufacturer of graphene-based brain engineering systems, Motif Neurotech, a Texas developer of compact implanted brain stimulation devices for treating depression, and REVAI, a Canadian manufacturer of AI-powered vagus nerve stimulation systems for learning and wellness applications. Other presenting companies are Neural Dynamics Technologies, NeuroSigma, Roga Life, NXTStim, PathMaker Neurosystems, NeuronOff, WISE Srl, Sana Health, and Zeto Inc.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic and MCRA are Silver Sponsors, and the Cleveland FES Center is Bronze Sponsor.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: https://www.neurotechreports.com/

Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum

NEW YORK, N.Y. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Entrepreneur presenters at the conference include Attila Borbath, CEO of Synergia Medical, a European firm developing an optical vagus nerve stimulation system, Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, Jennifer Ernst, CEO of Tivic Health, Manfred Franke, CEO of Neuronoff Inc., and Anuj Bhardwaj, CEO of SecondWave Systems Inc.

Peter Staats, a bioelectronic medicine pioneer and co-founder and chief medical officer of electroCore Medical, will keynote the conference. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for a number of disorders, including COVID, and his patents have led to the use of novel pharmacologic agents. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society.

Other speakers at the 2022 event include Marom Biksom, professor of biomedical engineering at City College of New York, Imran Eba, partner at Action Potential Venture Capital, Chihiro Hosoya, head of venture management and business development at Astellas Pharma, Eric Hudak, program director at the National Institutes of Health, and Hannah Claridge from TTP plc in the U.K.

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.

MST is the Platinum Sponsor of this year's event, while Valtronic is the Silver Sponsor.

Key topics will include promising new indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This fifth-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry."

For more information on the 2022 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

RELATED LINKS:
https://www.neurotechreports.com/

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Related link: http://www.neurotechreports.com/

Pure Transplant Solutions Announces Collaboration with Innobiochips to Develop Personalized Diagnostics for Post-Transplant Monitoring and Early Detection of Transplant Rejection

AUSTIN, Texas /ScoopCloud/ -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Innobiochips (IBC), a developer of innovative immunoassays and the SirYus™ diagnostic platform technology, to develop personalized HLA diagnostics that will detect and quantify donor specific antibodies (DSA's) in post-transplant settings and provide the basis for post-transplant monitoring and early detections of transplant rejection.

The research is being led by Innobiochips co-founders Drs. Vianney Souplet and Christophe Olivier, and Dr. Rico Buchli, VP of Products and Services at PTS. The collaboration aims to develop and validate new individualized, allele specific HLA-antibody diagnostics. The initial goals of the collaboration are to quickly develop the first commercial prototype and gather the data needed to validate the platform with leading community experts. The companies are optimistic that they will be able to rapidly provide a new portfolio of allele specific diagnostics to HLA lab directors, transplant clinicians and transplant patients that do not currently exist. These new diagnostics would enable personalized, easy to use, and quantifiable sequential monitoring of patient specific DSA levels, the result of which would provide a new pro-active window for clinicians to implement earlier graft saving interventions for transplant recipients.

"Between our two companies, we feel that we already have the ingredients needed to provide a new set of tools to those who care for transplant patients," Dr. Buchli stated. "Our proteins solve a number of important challenges on the serological side while the Innobiochips SirYus platform provides a very easy to use and elegant way to manufacture discrete, allele specific tests with the necessary controls, it really is a powerful combination."

"Over the past years, our companies have been exploring ways to combine our complementary technologies to create breakthrough diagnostics in the transplant market. PTS has the in-depth knowledge in HLA proteins and IBC has demonstrated that its technology is incredibly flexible and can enable as many as 144 serological assays at the same time in a single well, providing the transplantation departments an outstanding and new solution for HLA detection," Dr Souplet stated.

About Pure Transplant Solutions, LLC

Pure Transplant Solutions, LLC was founded in 1999 in order to leverage the leading research in HLA protein of parent company, Pure Protein, LLC, into solutions to address a growing list of needs in organ transplantation.

Learn more: https://www.puretransplant.com/

About Pure Protein, LLC

Pure Protein, LLC is a biotechnology company funded and managed by Emergent Technologies, Inc. that is focused on the development and commercialization of proprietary technologies related to the human leukocyte antigen (HLA) system, formed and exclusively licensed from the University of Oklahoma. Pure Protein, in conjunction with its affiliates and subsidiaries, aims to bring novel therapies and diagnostic tools to patients across a wide range of application areas spanning from therapeutic development in the fields of oncology, autoimmunity, and infectious disease, to antibody mediated rejection in transplantation.

Through its new ecommerce website, www.hlaprotein.com, Pure Protein now offers academic and commercial researchers the ability to purchase individual HLA reagents to detect, profile, and monitor allele-specific immune responses, as well as HLA peptide epitope binding services to aide in improving the design of vaccination and therapeutic targeting strategies.

About Innobiochips

Innobiochips is a diagnostic company committed to provide innovative multiplex immunoassays and aims to position its technology, SirYus™, as a new standard for In Vitro Diagnostics. As of today, Innobiochips has developed and produces products dedicated to transplantation and immunodeficiency and is partnering with several major players to incorporate the SirYus technology into larger IVD applications.

Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Innobiochips (IBC).

Related link: https://www.puretransplant.com/

Pure Transplant Solutions Announces Collaboration with Northwestern University to Develop Novel Reagents for Enhanced Characterization of HLA DQ Antigens in Transplant Rejection

AUSTIN, Texas /ScoopCloud/ -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Northwestern University, a world leader in HLA DQ antigen research.

The focus of the collaboration is to develop and test novel HLA reagents created by PTS that may be used for enhanced analysis and characterization of DQ antigens, an HLA Class II type that is increasingly gaining importance in causing rejection in transplant patients.

The research is being led by Dr. Anat Tambur, Director of the Transplant Immunology Laboratory and Comprehensive Transplant Center at Northwestern University Feinberg School of Medicine, and Dr. Rico Buchli, VP of Products and Services at PTS.

"The Tambur lab at the Comprehensive Transplant Center, Northwestern University, Chicago, is focusing on understanding the immunogenicity of HLA-DQ antigens and its role in antibody-mediated rejection in solid organ transplantation," said Dr. Tambur. "Increasing evidence has demonstrated that DQ mismatches between transplant recipient and donor are the most common to induce de novo donor-specific antibodies (DSA). HLA-DQ antibodies are likely also the most detrimental to graft survival. Understanding the unique structural and molecular properties that make the HLA-DQ molecule so pathogenic may eventually help us better predict which mismatches will induce harmful antibody formation, and which are more permissible. This work requires availability of purified HLA-DQ and other HLA class II molecules, maintaining high physiologic accuracy of the three-dimensional structure. Our collaboration with Pure Transplant Solutions allows us to develop unique approaches to study the unique involvement of HLA-DQ in transplant immunology."

"In the last years, we have seen a re-emerging role of HLA-DQ in transplantation medicine with increasing evidence that DQ mismatches between transplant recipient and donor are most detrimental to graft survival," said Dr. Buchli. "Our panel of highly representative HLA-DQ alleles will help to drive novel research to prevent transplant rejection and to contribute to more insight into DSA responses and we are thrilled to be working with Dr. Tambur, a world leader in this field."

About Pure Transplant Solutions, LLC

Pure Transplant Solutions, LLC was founded in 1999 in order to leverage the leading research in HLA protein of parent company, Pure Protein, LLC, into solutions to address a growing list of needs in organ transplantation. Visit: www.puretransplant.com

About Pure Protein, LLC

Pure Protein, LLC is a biotechnology company funded and managed by Emergent Technologies, Inc. that is focused on the development and commercialization of proprietary technologies related to the human leukocyte antigen (HLA) system, formed and exclusively licensed from the University of Oklahoma. Pure Protein, in conjunction with its affiliates and subsidiaries, aims to bring novel therapies and diagnostic tools to patients across a wide range of application areas spanning from therapeutic development in the fields of oncology, autoimmunity, and infectious disease, to antibody mediated rejection in transplantation.

Through its new ecommerce website, www.hlaprotein.com, Pure Protein now offers academic and commercial researchers the ability to purchase individual HLA reagents to detect, profile, and monitor allele-specific immune responses, as well as HLA peptide epitope binding services to aide in improving the design of vaccination and therapeutic targeting strategies.

Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Northwestern University, a world leader in HLA DQ antigen research.

Related link: https://www.puretransplant.com/

Pure Transplant Solutions Announces Collaboration with the University of Alabama at Birmingham to Develop Memory B Cell-Directed Diagnostics for HLA-Sensitized Patients

BIRMINGHAM, Ala. /ScoopCloud/ -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with The University of Alabama at Birmingham (UAB), a leading institution in transplant research, to develop a new class of transplant diagnostics aimed at the detection and identification of HLA-specific memory B cells which are poised to produce HLA-specific immunoglobulin injurious to transplanted grafts.

The research is being led by Dr. Frances Lund, Charles H. McCauley Professor and Chair Department of Microbiology, Dr. John Killian, resident in the Department of Surgery, and Dr. Rico Buchli, VP of Products and Services at PTS, and focuses on using PTS's newly created Class I and Class II biotinylated soluble HLA (sHLA) proteins to understand the breadth and specificity of HLA-reactive B cells in sensitized individuals. These proprietary HLA molecules can be utilized in standard flow cytometry workflows for easy processing and analysis that the parties hope will provide a new tool for clinicians and researchers to use when caring for transplant patients.

Almost all previous work on HLA sensitized individuals has relied upon assays that detect circulating anti-HLA antibodies. The goal is to determine the reactivities of HLA-reactive B cells in these sensitized patients and compare these reactivities to those that are present among circulating anti-HLA antibodies. Using panels of biotinylated HLA molecules in combination with various tetramerized fluorescent reagents allows the interrogation of the specific B cell receptors expressed by HLA-reactive B cells.

"Prevention of B cell activation and proliferation is crucial for the survival of a transplant patient. For patient monitoring, identifying the right approach to immune profiling at each stage of clinical development-including the later stages, when it is often considered impractical to include these approaches-may be critical for identifying predictors of rejection responses, or monitoring immunosuppression efficacy", said Dr. Buchli. "Flow cytometric analysis using our fluorescent tagged HLA products have the capabilities needed to meet the increased demands to detect, identify, and monitor HLA-specific memory B cells."

"Our research at the University of Alabama at Birmingham seeks to improve the success of organ transplants," said John Killian, Jr., M.D., a research resident in the UAB Department of Surgery. "One problem is that following pregnancy or transplant, patients form antibodies against non-self HLA molecules. These antibodies comprise a major barrier to transplantation, and they exacerbate gender and racial disparities for thousands of people who await a life-saving transplant. Thus, we want to understand the breadth and specificity of HLA-reactive memory B cells in sensitized women. Pure Protein's extensive selection of recombinant HLA molecules will be integral to our projects, allowing us to pair fluorescence-activated cell sorting of HLA-reactive B cells with subsequent analysis of recombinant-antibody specificities. An improved understanding of the phenotype and specificity of HLA-reactive B cells will offer new opportunities to diagnose and treat HLA sensitization."

About Pure Transplant Solutions, LLC

Pure Transplant Solutions, LLC was founded in 1999 in order to leverage the leading research in HLA protein of parent company, Pure Protein, LLC, into solutions to address a growing list of needs in organ transplantation. Visit: www.puretransplant.com

About Pure Protein, LLC

Pure Protein, LLC is a biotechnology company funded and managed by Emergent Technologies, Inc. that is focused on the development and commercialization of proprietary technologies related to the human leukocyte antigen (HLA) system, formed and exclusively licensed from the University of Oklahoma. Pure Protein, in conjunction with its affiliates and subsidiaries, aims to bring novel therapies and diagnostic tools to patients across a wide range of application areas spanning from therapeutic development in the fields of oncology, autoimmunity, and infectious disease, to antibody mediated rejection in transplantation.

Through its new ecommerce website, http://www.hlaprotein.com/, Pure Protein now offers academic and commercial researchers the ability to purchase individual HLA reagents to detect, profile, and monitor allele-specific immune responses, as well as HLA peptide epitope binding services to aide in improving the design of vaccination and therapeutic targeting strategies.

About the University of Alabama Birmingham

Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham, a part of the University of Alabama System, is an internationally renowned research university and academic medical center with over $600 million in research awards annually, as well as Alabama's largest employer, with some 23,000 employees, and has an annual economic impact exceeding $7 billion on the state. The pillars of UAB's mission include education, research, innovation and economic development, community engagement, and patient care. Learn more at https://www.uab.edu/.

Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with The University of Alabama at Birmingham (UAB), a leading institution in transplant research.

Related link: https://www.puretransplant.com/

‘Special Twins’ Tour of Duty Makes History

HOWELL, N.J. /ScoopCloud/ -- Mid-Atlantic Multi-Specialty Surgical Group, L.L.C. (MAMSURG) is announcing that two of their providers, Vince and Vance Moss, Army Reservists, Colonels, and G.H.O.S.T. surgeons for U.S. Special Operations Command, are returning home from Afghanistan in support of Operation Resolute Support following a unique, unprecedented 6 month tour of duty, making history by serving with the special forces as forward trauma surgeons, side by side.

Family members serving simultaneously in combat is rare, but even more uncommon is twins serving together in the same combat theater with the U.S. Special Operations. This rarity has become a reality. Twin brothers, Colonels Vince and Vance Moss (49 years old) have served on active duty together with the 909th General Hour Offset Surgical Team (G.H.O.S.T.), U.S. Special Operations Command in Afghanistan since January 2020. This act alone has not been known to be done on record. They had the unique experience of providing trauma surgery for the special forces during their missions. While serving, Vince's wife gave birth to his son, making this homecoming even more special when he meets him for the first time.

"It's been unbelievable serving with Vance in combat with so many talented warriors. I think it allowed me, once and for all, the opportunity to show my baby brother who's the better surgeon. I'm certainly looking forward to getting home and meeting my son for the first time and sharing that experience with my brother," said Vince Moss.

"It's been a great experience serving with the special forces environment with my brother at my side. I can't truly put into words how to describe the many reactions we received when people saw us. It was quite extraordinary. I'm looking forward to meeting my nephew for the first time," said Vance Moss.

The twins are originally from the Washington D.C. area. Penn State and Temple graduates, they are in private practice in New Jersey. The Moss brothers have been in the Army Reserves for over 15 years and served multiple tours in Iraq and Afghanistan. They have received many accolades for their work including being named ABC World News Tonight "Person(s) of the Year" and multiple invites to the White House.

The Moss brothers are scheduled to be returning home tentatively on June 30, 2020.

For more information, visit: https://www.mamsurg.com/.

About MAMSURG, L.L.C.:

Based in Howell, New Jersey, MAMSURG, L.L.C. is a surgical group of board-certified surgeons skilled in a variety of specialized techniques from renal transplantation, general surgery, urology and thoracic surgery. More importantly, their dedication to providing top notch, large center quality of care to the communities of New Jersey and the military is at the top of their agenda. The practice was started by Vince and Vance Moss in 2005 which the goal of focusing on underprivileged populations. For more information, visit: https://www.mamsurg.com/.

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-07070s2p-Moss-Bros-2020-300dpi.jpg
*Photo caption: Surgeons/Colonels Vince (left) and Vance (right) Moss in an undisclosed location in Afghanistan with US Special Operations.

Mid-Atlantic Multi-Specialty Surgical Group, L.L.C. (MAMSURG) is announcing that two of their providers, Vince and Vance Moss, Army Reservists, Colonels, and G.H.O.S.T. surgeons for U.S. Special Operations Command, are returning home from Afghanistan in support of Operation Resolute Support following a unique, unprecedented 6 month tour of duty.

Related link: https://www.mamsurg.com

Record Early Enrollment for Lower Extremity Fellows, Residents & Young Surgeon 3rd Annual Course

SAN DIEGO, Calif. /ScoopCloud/ -- Magnifi Group, Inc. and Bespa Global, LLC, co-organizers of the program, announced today that despite the change of date for its 3rd Annual Lower Extremity IEP Fellows, Residents and Young Surgeons Course it is still experiencing record early registration. The course, originally scheduled for May 1-3 will take place from November 6-8, 2020 at The Omni Downtown, Austin, Texas.

This increased level of interest has been attributed to COVID-19 and the lack of in-person training opportunities for these young clinicians.

Lower Extremity IEP Program Co-chair, Dr. Donald R. Bohay, who serves as Professor Orthopaedic Surgery, Michigan State University and the Director of Grand Rapids Orthopedic Foot and Ankle Fellowship Program, said now more than ever, the prior and incoming class of Orthopedic Fellows and Final Year Podiatric Residents will significantly benefit from the Lower Extremity IEP Course.

"Given the current pandemic, these residents and fellows have not had the opportunity to participate in the usual array of cases, cadaver labs and in-person educational sessions," Dr. Bohay said. Dr. Bohay added that the impact is not limited to large COVID-19 cluster cities - it has impacted centers and schools across the country.

The Lower Extremity IEP Fellows, Residents & Young Surgeons' Course has been specifically developed to educate Fellows, Residents and Young Surgeons on current topics related to the practice of foot and ankle surgery, as well as to assist attendees with the transition from academics to practicing surgeon. The classroom format for the course is highly interactive; all sessions conclude with question/answer sessions and panel discussions. The course will be limited to 35 attendees to accommodate a didactics rotation schedule of up to 15 tables hosted by medical device and biologics companies. Cadaver labs will also be offered during the intense 21/2 day course.

Dr. Christopher L. Reeves, Program Co-chair and Faculty and Director of Research Advent Health Podiatric Surgical Residency, said he anticipates registration will fill up by mid-September. "The registration process will pick up even faster once the outgoing group of fellows and residents know their schedules and the incoming group are firmly in place."

The Lower Extremity IEP Fellows, Residents & Young Surgeons' Course is led by Dr. Gregory C. Pomeroy, Clinical Associate Professor of Surgery at the University of New England.

Magnifi Group, Inc. is a developer of a FDA-compliant eLearning platform for the medical device and biologics industries. The company also hosts the Spine IEP Live Fellows Course; the Lower Extremity IEP Live Fellows Course and the Hip and Knee IEP Live Fellows Course.

Bespa Global, LLC is dedicated to improving patient care through education and advancements in medical science. Our unique model is changing the way Medical Companies and Health Care Professionals work together to improve patient outcomes.

Learn more at: https://www.lowerextremity-iep.com/

For Additional Information Contact:

Laura McClain: lmcclain@magnifigroup.com

Chris Newell: cnewell@bespaglobal.com

*IMAGE link for media: https://www.Send2Press.com/300dpi/20-0521s2p-seal-lower-iep-300dpi.jpg

Magnifi Group, Inc. and Bespa Global, LLC, co-organizers of the program, announced today that despite the change of date for its 3rd Annual Lower Extremity IEP Fellows, Residents and Young Surgeons Course it is still experiencing record early registration. The course, originally scheduled for May 1-3 will take place from Nov. 6-8, 2020 at The Omni Downtown, Austin, Texas.

Related link: http://www.magnifigroup.com/

Record Early Spine Fellows & Young Surgeon Enrollment for 10th Annual November Spine IEP Course

SAN DIEGO, Calif. /ScoopCloud/ -- Magnifi Group, Inc., announced today it is experiencing record early registration for its 10th Annual Spine IEP Fellows & Young Surgeons' Course (Spine Interactive Educational Program). The course will be conducted November 20-22 at The Fairmont Hotel, Austin, Texas.

A significant number of US Spine Fellowship Directors attribute the stepped-up early registration due to COVID-19.

Spine IEP Faculty member, Dr. R. Todd Allen, who serves as Associate Clinical Professor of Orthopaedic Surgery and Spine Surgery at the University of California, San Diego (UCSD) and Director of the University's Spine Fellowship program, said, now more than ever, the incoming Spine and Neuro Fellowship class of 2020-2021 will significantly benefit from the Spine IEP Course.

"Given the current pandemic, final-year Orthopaedic residents looking ahead to their spine fellowships, have not had the opportunity to take full advantage of their final residency year when it comes to surgical electives - as they relate to didactic spine work, labs and clinical training," Dr. Allen said. Dr. Allen added that even those schools offering a Chief Resident Rotation have been impacted.

The Spine IEP Fellows & Young Surgeons' Course will be limited to 50 attendees to accommodate a didactics rotation schedule of 45 tables hosted by medical device and biologics companies. Four cadaver labs will also be offered during the intense 21/2 day course.

The Spine IEP has been specifically developed to educate spine and neurosurgery Fellows and Young Surgeons on current topics related to the practice of spine and neurosurgery, as well as to assist attendees with the transition from academics to practicing surgeon. The classroom format for the course is highly interactive; all sessions conclude with question/answer sessions and panel discussions.

Laura McClain, Course Coordinator, said she anticipates registration fill up as early as July/August. "The upcoming course will represent the largest gathering ever of Spine Fellows and Young Surgeons for an educational event of this kind," McClain said. "Our sponsors also recognize that this course represents a significant opportunity to expose their latest techniques, products and treatments to the next-generation of spine and neuro surgeons," McClain added.

The Spine IEP Fellows & Young Surgeons' Course is led by Dr. Frank Phillips, Professor and Director, Division of Spine Surgery and Fellowship Co-Director, Spine Surgery at Rush University Medical Center, Chicago, Ill. To register: https://www.spine-iep.com/sfc/register.html

According to Magnifi data, an average of 70-80 spine Fellows enters the US market each year as practicing spine surgeons. Of these, 48-50 Fellows & Young Surgeons are expected to attend the upcoming course.

Magnifi Group, Inc. is a developer of an FDA-compliant eLearning platform for the medical device and biologics industries. The company also hosts the Spine IEP Live Fellows Course; the Lower Extremity IEP Live Fellows Course and the Hip and Knee IEP Live Fellows Course.

For Additional Information Contact:
Laura McClain: lmcclain@magnifigroup.com

Magnifi Group, Inc., announced today it is experiencing record early registration for its 10th Annual Spine IEP Fellows & Young Surgeons' Course (Spine Interactive Educational Program). The course will be conducted November 20-22 at The Fairmont Hotel, Austin, Texas.

Related link: http://www.magnifigroup.com/

Charleston Oral and Facial Surgery Recognized as ‘Best of’ in Summerville and Mount Pleasant

CHARLESTON, S.C. /ScoopCloud/ -- Charleston Oral and Facial Surgery (COAFS) was voted a 2019 Reader's Choice recipient by the readers of "Journal Scene." Named Best Oral Surgeons in the annual Best of Summerville competition, COAFS will be featured in the 2019 Reader's Choice special edition. Winners in all categories were announced at a party held at The Village of Summerville on February 25, 2020.

In addition to accolades from Summerville, COAFS was recently named 2020 Best Oral Surgery Practice by Mount Pleasant Magazine. Nearly 50,000 votes were cast by magazine readers.

Led by a team of highly trained, board-certified oral surgeons - Dr. Edward R. Strauss, DMD, MD; Dr. Aaron P. Sarathy, DMD; Dr. A Drane Oliphant, DMD, MD; Dr. Graham Lee, DMD; and Dr. Scott H. Godwin, DMD - Charleston Oral and Facial Surgery has six convenient locations in the Lowcountry area, including Charleston, North Charleston, Summerville, Mount Pleasant, Bluffton and Knightsville.

Some of the practice's specialties include: total smile transformation, full-arch dental implants, implant-supported dentures, wisdom teeth extraction, same-day dental implants and corrective jaw surgery, to name just a few. Using advanced surgical techniques and state-of-the-art, cutting-edge technology, COAFS maintains a patient-centric philosophy to ensure that every client, regardless of the treatment, receives the ultimate patient experience.

"At COAFS, our surgeons are constantly striving to provide the highest quality care to our patients," said Dr. Aaron P. Sarathy, DMD. "We strive to give back to the community and to know our patients are recognizing this is a true honor for our doctors and team."

To learn more about COAFS, visit https://www.charlestonoralandfacialsurgery.com/.

For media inquiries, contact Stacey Kole with Branded Pros at 480.221.5818 or email stacey@brandedpros.com.

About Charleston Oral and Facial Surgery

COAFS has six locations in the Lowcountry, S.C. area, where its highly trained, board-certified surgeons provide patients with state-of-the-art treatment. With a commitment to cutting-edge technology and ongoing education, Charleston Oral and Facial Surgery offers the most advanced surgical techniques coupled with compassionate to produce the ultimate patient experience - every single time.

More information: https://www.charlestonoralandfacialsurgery.com/

Charleston Oral and Facial Surgery (COAFS) was voted a 2019 Reader's Choice recipient by the readers of "Journal Scene." Named Best Oral Surgeons in the annual Best of Summerville competition, COAFS will be featured in the 2019 Reader's Choice special edition. Winners in all categories were announced at a party held at The Village of Summerville on February 25, 2020.

Fifteen Neurotechnology Startups to Present at the 2019 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Josh Makower, general partner at VC firm New Enterprise Associates, will keynote on the first day of the conference. Makower is cofounder of the Stanford Byers Biodesign Center and also founder and executive chairman of ExploraMed, a medical device incubator that has created eight companies over the past 20 years.

Robert Knight, professor of psychology and neuroscience and director emeritus of the Helen Wills Neuroscience Institute at UC Berkeley, will deliver the keynote on the second day of the event. Knight is the recipient of the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health for distinguished contributions to neurological research. He is also the chief science advisor of Neurofocus Inc., the consumer neurotech spinoff company acquired by market research firm Nielsen.

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to clinical trials, securing funding, the new competitive landscape in neuromodulation, closed-loop stimulation, and neurorehabilitation. New this year is an editorial roundtable featuring Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta, who will each offer their perspectives on issues confronting the industry.

Among the companies presenting this year are Saluda Medical, Nia Therapeutics, Neuroelectrics, Humm, Evoke Neuroscience, Neural Dynamics Technologies, Spark Biomedical, Thermaquil, Humm, Neuraura, CareWear, Rune Labs, Neural Signals, and BIOS.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Maynard Cooper and Integer are Silver Sponsors, and RBrooks Group, Senso Medical, and the Cleveland FES Center are Bronze Sponsors.

"We're excited about the lineup of speakers at this year's event," said James Cavuoto, editor and publisher at Neurotech Reports. "As in the past, attendees will have many opportunities to interact with potential partners and colleagues."

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/leadersforum.html.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: http://www.neurotechreports.com/

Surgery Center of Oklahoma Offers Procedure Financing Through MedPlan Credit

OKLAHOMA CITY, Okla. /ScoopCloud/ -- Surgery Center of Oklahoma now offers surgical procedure financing through their financing partner, MedPlan Credit of Tulsa.

Patients now have the opportunity to apply for financing, using MedPlan's technology platform, through a link on SCOK's website or through a form on Medplan's website. Applicants are assessed and receive an immediate credit decision, followed by automated verification steps for final approval and setup.

"At Surgery Center of Oklahoma, we believe that a different approach to health care delivery is necessary, one involving transparent and direct pricing," said Dr. Keith Smith, SCOK's CEO. "Transparent, direct, package pricing means the patient knows exactly what the cost of the service will be upfront. Patients who choose Surgery Center of Oklahoma and need to finance their procedure are directed to MedPlan's online financing application. MedPlan Credit is the best we have seen at providing an easy application process and a high percentage of approved applications."

MedPlan Credit is an online lending platform dedicated to creating an easy lending process for health care consumers. Through its robust and efficient digital platform, MedPlan makes the whole lending process fast and convenient.

About Surgery Center of Oklahoma:

The Surgery Center of Oklahoma is 32,535-square-foot, state-of-the-art multispecialty facility in Oklahoma City, owned and operated by approximately 40 of the top surgeons and anesthesiologists in central Oklahoma with 112 doctors on their surgical staff. SCOK's pricing for surgical procedures are a fraction of the prices charged at nonprofit hospitals. Since SCOK controls every aspect of the facility, they are able to eliminate wasteful operating room practices while providing the very best quality care to their patients. More information is available at https://surgerycenterok.com/.

About MedPlan Credit:

MedPlan Credit partners with health care providers to offer financing for high deductibles and other out-of-pocket costs. MedPlan loans allow patients to receive health care when they need it instead of waiting until they can afford it. MedPlan offers a quick and easy application/approval process with competitive, affordable interest rates. More information is available at https://www.medplancredit.com/

Surgery Center of Oklahoma now offers surgical procedure financing through their financing partner, MedPlan Credit of Tulsa. Patients now have the opportunity to apply for financing, using MedPlan's technology platform, through a link on SCOK's website or through a form on Medplan's website.

Related link: https://surgerycenterok.com/

New Advancement Allows for Septoplasty Procedure with Minimal Downtime

ATLANTA, Ga. /ScoopCloud/ -- Dr. Aaron Rogers and Advanced Ear Nose & Throat Associates, a leading Atlanta-based Otolaryngology medical practice, announces further advancement in office-based nasal surgery. New techniques allow for a full spectrum of corrective nasal surgery to now be done in the office with just minimal recovery.

The medical industry is constantly evolving with new techniques and technologies that improve the recovery process and results for patients. One of the newest advancements to hit the market is the development of an incisionless septoplasty that is minimally invasive and has a much faster recovery period than traditional septoplasty procedures. Dr. Aaron Rogers, based in the Metro Atlanta Area, has perfected this technique in order to help patients with nasal allergies, sinus infections and other nasal problems.

No-Scalpel septoplasty is a new procedure that is performed under local anesthesia utilizing the the Acclarent Relieva TRACT(R) device. The procedure utilizes pressurized inflatable dilators to remodel the nasal septal spurs and deflection that lead to nasal blockage. It takes just a few minutes, as opposed to traditional septoplasty procedures that require general anesthesia and are performed over the course of a few hours in an operating room.

The no-scalpel technique can be performed alongside other nasal procedures including balloon sinuplasty, turbinate reduction or nasal valve collapse repair. This procedure is recommended for adults who have nasal congestion or suffer from allergies, as well as patients who have had prior septoplasty but a residual spur.

One of the most attractive benefits of this treatment is the fast recovery period that lasts just a couple of days with mild discomfort and minimal bleeding. Patients can go to work the following day and costs are lower than traditional surgeries because anesthesiology and facility costs are avoided.

Dr. Rogers of Advanced Ear, Nose and Throat Associates is one of the first doctors in the Atlanta area to offer this new advanced technique. He has seen firsthand the increased benefits it provides to patients.

According to Dr. Rogers, "Treating deviated septum in the office is finally a practical reality, opening to doors to comfortable and comprehensive in-office nasal surgery."

More information: https://AdvancedENTpc.com/incisionless-septoplasty-with-dr-rogers/

VIDEO (YouTube): https://youtu.be/qts5WGeDrsg

Dr. Aaron Rogers and Advanced Ear Nose & Throat Associates, a leading Atlanta-based Otolaryngology medical practice, announces further advancement in office-based nasal surgery. New techniques allow for a full spectrum of corrective nasal surgery to now be done in the office with just minimal recovery.

Related link: https://advancedentpc.com/

Switzerland-based Brain Assessment Research Center (BrainARC-Chur) launches US division (BrainARC-America) headed by leading Neuroscience experts

BOSTON, Mass. /ScoopCloud/ -- Brain ARC Chur Switzerland partners with Sadar Psychological Services (Philadelphia) and Boston NeuroDynamics (Boston) to launch Brain ARC America, in order to bring more cutting edge evaluations to improve treatment for common brain disorders such as ADD/ADHD, anxiety, depression, age-related memory loss, autism, chronic pain/migraines, epilepsy, sleep disorders and a myriad of other issues such as including how to improve your brain to increase its efficiency in everyday life.

HBImed AG has been an industry leader in clinical brain research for over a decade and provides medical-psychological services in particular by supporting brain research diagnostics with therapeutic advice in the context of various brain dysfunctions. They have set forth industry challenging standards by actually measuring the brain's activity and comparing it to a sophisticated, FDA approved database which is the most thorough and comprehensive aggregate databank of its kind.

Both Boston Neurodynamics and Sadar Psychological Services have been using this neuroscience research to successfully determine the best treatments since HBImed AG was founded. Because of their collective expertise in implementing the BrainARC system in their respective practices, Drs. Sadar, Martinez and Morales have been exclusively selected to herald in the expansion and create BrainARC-America.

BrainARC-America will capitalize on the vast amount of continuing research, their breadth and depth of experiences within the mental health field, coupled with each other's unique yet complimentary backgrounds in order to develop individualized brain assessments in order to ascertain how each person's brain is functioning in order to improve their quality of life.

Brain ARC-America principles are Diana Martinez, MD, MSc, PhD, Board Certified in Neurofeedback, Angelika Y. Sadar, MA-Clinical Psychology, Board Certified in Neurofeedback and Heart Rate Variability, Leon Morales-Quezada, MD, MSc, PhD, MPH, and Mitchell Sadar, M.A., PhD., Board Certified in Neurofeedback and Heart Rate Variability.

Andreas Müller of BrainARC-Chur and HBImed Brain Diagnostics states "BrainARC-Chur, along with HBImed AG is happy to partner with BrainARC-America. It has been our goal to introduce this highly researched and evidence based method that helps to understand the individual's brain functioning to develop an individualized treatment plan to the United States for quite some time and finally we have the right leaders."

"We are pioneers in helping people improve their lives by measuring objectively how their brain functions so that the best individualized treatments can be offered. This is in contrast to the more traditional methods of diagnosing based on just patient report and observed symptoms," said Dina Martinez.

By objectively measuring biomarkers in the brain, we are able to add to the traditional, limited methods of clinical observation. As a result, the patient receives validation of the source of their behavioral distress. Very often, when given results, parents will comment.

"This is what I was waiting for. This is the first time I have received an explanation of what is going on in my child's brain. Now our family has hope for our child's future," said Angelika Sadar.

"This evaluation process can help identify biomarkers that can guide the prescribing of medication to decrease the number of children who are over medicated or experience the negative side effects of medications unnecessarily," said Mitchell Sadar.

"BrainARC US neurophysiological and cognitive evaluations compliment traditional medical diagnostic tools helping clinicians to develop adequate therapeutic interventions," said Leon Morales.

Learn more about Brain ARC-America
(610) 933-9440
https://brainarcevaluations.com
info@brainarcevaluations.com

Boston Neurodynamics
(617) 855-9295
https://bostonneurodynamics.com
info@bostonneurodynamics.com

Sadar Psychological
(610) 933-9440
https://sadarpsych.com
admin@sadarpsych.com

Brain ARC Chur Switzerland partners with Sadar Psychological Services (Philadelphia) and Boston NeuroDynamics (Boston) to launch Brain ARC America, in order to bring more cutting edge evaluations to improve treatment for common brain disorders and a myriad of other issues such as including how to improve your brain to increase its efficiency in everyday life.

Related link: https://brainarcevaluations.com

Study Identifies Boston’s Top-Rated Plastic Surgeons

BOSTON, Mass. /ScoopCloud/ -- An analysis of multiple online rating sources has shed light as to whom Boston-area plastic surgical patients consider the area's top plastic surgeon. According to actual patient ratings gathered from five different rating platforms, Dr. Jeffery Spiegel, of The Spiegel Center, was ranked as the area's top plastic surgeon, receiving more five-star ratings from his patients than any other plastic surgeon.

The study, conducted by John C. Anderson Ph.D., a former professor of management at UCLA and consultant in the plastic surgery industry, compiled patient ratings from five key platforms-Google, Facebook, RealSelf, Vitals.com, and RateMD.com, looking specifically at which physicians had received five-star ratings from patients, and for which procedures.

Dr. Spiegel received 221 five-star ratings. The next surgeon with the most five-star ratings, Dr. Jeffrey Darrow, earned 125 top marks from his patients. Others, with fewer top marks, included Boston plastic surgeons Dr. Sean Doherty, Dr. Richard Bartlett, Dr. Samuel Lin, Dr. George Volpe, Dr. Leonard Miller, Dr. Summer Slavin, and Dr. Joseph Russo.

The number of five-star reviews earned by the surgeons ranged from 12 to 221.

In addition, the study looked at which procedures earned the doctors the most top reviews. These tended to flow along the lines of each practice's specialty. Dr. Spiegel, for example, was ranked highest in facial plastic surgery (rhinoplasties, face lifts, injectables, blepharoplasties, and facial feminization surgeries).

Other surgeons were noted for their skills in breast augmentation and reduction, injectables, rhinoplasty, and gynecomastia.

Patient ratings are one indicator of physician quality along with board certification, academic credentials, and experience.

The complete study is available at: https://www.drspiegel.com/general/the-best-plastic-surgeons-in-boston/

About The Spiegel Center:

The Spiegel Center is a state-of-the-art Facial plastic surgery center that specializes in cosmetic and facial feminization surgery for patients in Boston. Learn more at: https://www.drspiegel.com/

An analysis of multiple online rating sources has shed light as to whom Boston-area plastic surgical patients consider the area's top plastic surgeon. According to actual patient ratings gathered from five different rating platforms, Dr. Jeffery Spiegel, of The Spiegel Center, was ranked as the area's top plastic surgeon.

Related link: https://www.drspiegel.com/

New Market Research Report on Bioelectronic Medicine Forecasts $16.6B Market

SAN FRANCISCO, Calif. /ScoopCloud/ -- A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025. "The Market for Bioelectronic Medicine: 2020-2025" takes an in-depth look at the technology, markets, competitors, research, and growth rates in key application areas in the years 2020 through 2025.

"Bioelectronic medicine represents one of the most promising areas of healthcare and medical technology," said James Cavuoto, editor and publisher of Neurotech Reports. "Our team of editors and market research forecasters has more experience and expertise in this area than any other market intelligence organization."

The research report forecasts U.S. and worldwide revenue, compound annual growth rates, and competitor market shares for bioelectronic medicine devices in several key indications, including inflammatory disorders, hypertension, gastrointestinal disorders, urological disorders, cardiac disorders, metabolic disorders, and ENT disorders. It features in-depth profiles of established and startup bioelectronic medicine firms and key research institutions developing new bioelectronic and neuromodulation therapies.

A unique feature of this report is that it breaks down U.S. and worldwide revenue between core applications that conform to a classic definition of bioelectronic medicine-neuromodulation that affects an end organ-and applications that conform to an expanded definition that includes neuromodulation for neurological disorders. Also highlighted in the report is detailed information on key private and public funding agencies and venture capital firms that are investing in this space.

Authors of the report include Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta. Puerta is the former editor of the journal Bioelectronic Medicine. A team of prominent industry experts also contributed valuable input to the study including Tony Arnold, principal of the consulting firm Precys and former CEO of SetPoint Medical, and Victor Pikov, CEO of Medipace Inc. and former research platforms director at Galvani Bioelectronics.

The report is available through the Neurotech Reports website: http://www.neurotechreports.com/pages/mbmsumm.html.

About Neurotech Reports:

Neurotech Reports is the leading source of news and analysis specific to the neurotechnology industry. The firm publishes the monthly newsletter Neurotech Business Report, and also produces two annual investment conferences: the Neurotech Leaders Forum, now in its 19th year, and the Bioelectronic Medicine Forum, now in its second year. Neurotech Reports also offers strategic consulting services to commercial firms and research organizations in neuromodulation and bioelectronic medicine. Learn more at: http://www.neurotechreports.com/.

*VIDEO: Neurotech Reports editor James Cavuoto offered an overview of the report at the 2019 Bioelectronic Medicine Forum in New York - https://youtu.be/KHo6P-dYiYE

*IMAGE link for media: Send2Press.com/300dpi/19-0509s2p-nr-chart-300dpi.jpg
*Caption: "The Market for Bioelectronic Medicine: 2020-2025" examines core applications involving neuromodulation that affects an end organ, but also forecasts the market in an expanded definition that includes more traditional forms of neuromodulation.

A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025.

Related link: http://www.neurotechreports.com/

Atlantic Coast Surgical Suites performs first navigated reverse total shoulder at an ambulatory surgery center in New England

SEABROOK, N.H. /ScoopCloud/ -- Atlantic Coast Surgical Suites is an ambulatory surgery center designed for, and specializing in, outpatient joint replacement surgery. Today, Dr. Moby Parsons of The Knee, Hip and Shoulder Center performed the first outpatient reverse shoulder replacement here using the Exactech GPS (Guided Personalized Surgery) preoperative planning and navigation system.

According to Parsons, "There are very few centers around the country offering surgical navigation for shoulder replacement at an outpatient surgery center. This is the first such case in New England."

Dr. Parsons is one of the design surgeons for the Exactech GPS system. A preoperative CT scan provides a detailed 3D picture of the patient's arthritic shoulder. Images are then imported into a planning software that allows the surgeon to virtually perform the operation, selecting the right implants and their optimal position and orientation relative to the patient's individual anatomy. This plan can then be taken into the operating room where special instruments with trackers synced to a computer and camera system allow real time navigation of the surgical plan.

"Arthritis causes wear and erosion of the socket bone. Our goal during surgery is to restore patient anatomy as best we can. Planning and navigation substantially improve our accuracy compared to conventional instruments," Parsons notes.

Parsons, along with several other design surgeons and engineers, has done extensive research and development on surgical navigation in shoulder replacement and has been using this technology for almost 2 years since it became commercially available. Parsons was also the first surgeon in New Hampshire to perform a reverse shoulder replacement in 2004 and was recently inducted into the American Shoulder and Elbow surgeons, recognizing his expertise in shoulder surgery.

Advances in patient preparation, pain management, anesthetic techniques and surgical techniques now allow many patients to go home the same day as their joint replacement surgery. "Recovery in the comfort of home is both safe and highly satisfying for patients," Parsons notes.

"Our ambulatory surgery center specializes in orthopedic procedures with a highly dedicated staff who focus on same-day care day in and day out. Experience and expertise really matter to do this well. We are extremely fortunate to have a center like Atlantic Coast Surgical Suites where we can deliver high quality outpatient joint replacement."

Learn more at: https://www.orthopedicsnh.com/

Atlantic Coast Surgical Suites is an ambulatory surgery center designed for, and specializing in, outpatient joint replacement surgery. Today, Dr. Moby Parsons of The Knee, Hip and Shoulder Center performed the first outpatient reverse shoulder replacement here using the Exactech GPS (Guided Personalized Surgery) preoperative planning and navigation system.

Related link: https://www.orthopedicsnh.com/

Local Orthopaedic Surgeon to Discuss Advancements in Shoulder Replacement on the World Stage

PORTSMOUTH, N.H. /ScoopCloud/ -- Dr. Moby Parsons, a joint replacement specialist at the Knee, Hip and Shoulder Center in Portsmouth, N.H., helped to pioneer a surgical navigation tool that is now being widely used around the world to improve the results of shoulder replacement. Termed GPS for Guided Personalized Surgery, this technology allows the shoulder surgeon to preoperatively plan the operation on a computer system and then recreate that plan with great accuracy using intelligent surgical instruments that can link the patient's anatomy to the preoperative imaging.

The shoulder is a highly complex joint that undergoes wear and erosion from arthritis and tendon tears. Prior studies have demonstrated that when surgeons can better recreate a patient's native anatomy during reconstructive surgery, outcomes are improved in terms of range of motion, function and implant longevity.

"GPS effectively gives us 3-dimensional, x-ray vision and greatly improves our ability to restore normal anatomy," said Parsons, who has worked extensively with Exactech, Inc. in Gainesville, Fla. to bring this technology into the operating room.

Parsons, along with an international team of surgeons and engineers, helped to develop and validate the GPS system. Recently Parsons has worked with his team to research and refine standards in the preoperative planning process that may lead to better shoulder function, lower complications and improved implant durability.

"Comparing the way different surgeons approach the same case reveals that there is currently a lack on consensus about what is the ideal reconstruction for any given shoulder," Parsons notes. His research aims to narrow the range of acceptable solutions to achieve greater precision during shoulder replacement.

Parsons' research was recently selected for presentation at the International Congress for Shoulder and Elbow Surgery this September in Buenos Aires, Argentina. Hosted every 3 years, this is the largest gathering of shoulder experts in the world and provides an international stage for the team's work. "The acceptance of our study points to the widespread interest that surgeons have in these enabling technologies. We are honored to present our results and hope we can translate this work into improved standards for shoulder replacement in the future."

Parsons and the GPS Design Team continue to advance the capabilities of this system through ongoing research and development. "We have made a substantial leap forward over the last 3 years, but there is much left to learn and a tremendous opportunity to leverage technological innovations in the operating environment for the benefit of better surgical results."

Dr. Parsons performed a fellowship in shoulder surgery under famed, shoulder replacement pioneer Dr. Frederick Matsen. He is a founding member of the New England Shoulder and Elbow Surgeons where he recently hosted a panel discussion on computer-assisted preoperative planning. He is also a member of the American Shoulder and Elbow Surgeons. His prior research has won the prestigious Charles Neer Award for excellence in clinical outcomes studies. He will also be presenting results of clinical research on the reverse shoulder replacement at this year's American Academy of Orthopaedic Surgeons annual meeting in Las Vegas, Nev.

He currently operates at Portsmouth Regional Hospital in Portsmouth, N.H., Wentworth Douglass Hospital in Dover, N.H. and Atlantic Coast Surgical Suites in Seabrook, N.H.

Learn more about Dr. Parsons and The Knee, Hip and Shoulder Center at: https://www.orthopedicsnh.com/

Dr. Moby Parsons, a joint replacement specialist at the Knee, Hip and Shoulder Center in Portsmouth, N.H., helped to pioneer a surgical navigation tool that is now being widely used around the world to improve the results of shoulder replacement.

Related link: https://www.orthopedicsnh.com/

Sue Siegel to Keynote 2019 Bioelectronic Medicine Forum in NY

NEW YORK, N.Y. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announces that Sue Siegel, Chief Innovation Officer at GE and CEO of GE Ventures, will keynote the 2019 Bioelectronic Medicine Forum, which takes place in New York City on April 4, 2019. The second-annual event will be held at the Millennium Broadway Hotel & Conference Center in Times Square.

Sue has more than 35 years of corporate, entrepreneurial, and venture capital experience, all geared at turning untapped potential into real value. In this role, Sue leads GE Ventures, a multimodal innovation engine focused on accelerating promising start-ups, creating and launching new companies, licensing GE's intellectual property, developing new markets, and nurturing innovative ideas into scalable initiatives both inside and outside of GE.

Sue is currently a board member at Align Technologies (ALGN), Illumina, Inc. (ILMN), and MIT's The Engine. She has been recognized in Fortune as one of "34 Leaders Who Are Changing Health Care" and as one of "The 100 Most Influential Women in Silicon Valley" by Silicon Valley Business Journal.

Other speakers at this year's event include Imran Eba, partner at Action Potential Venture Capital, Evan Norton, divisional vice president at Abbott Ventures, Jeff Erb, senior director of business development at Medtronic, Kip Ludwig, associate professor at University of Wisconsin-Madison, Elliot Krames, past president of the International Neuromodulation Society, Marom Bikson, professor of biomedical engineering at City University of New York, Shai Gozani, CEO of NeuroMetrix Inc., and Victor Pikov, a former Galvani Bioelectronics scientist and now CEO of startup Medipace Inc.

Several promising bioelectronic medicine entrepreneurs will be presenting at the meeting. These include Daniel Powell, CEO of Spark Biomedical, Thomas Oxley, CEO of Synchron Inc., developer of the Stentrode device, Jennifer Ernst, CEO of Tivic Health, Don Deyo, CEO of FemPulse LLC, Doug Adams, CEO of Qura Inc., Nader Yaghoubi, CEO of PathMaker Neurosystems Inc., and Samuel Hamner, director of technology and product marketing at Cala Health. Also presenting will be Gaurev Sharma from Battelle and Jake Zabara from the Jacob Zabara Family Foundation. Dr. Zabara was the original developer of vagus nerve stimulation for epilepsy and a cofounder of Cyberonics Inc. (now LivaNova).

Key topics will include promising indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This second-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry."

For more information on the 2019 Bioelectronic Medicine Forum, contact Neurotech Reports at (415) 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announces that Sue Siegel, Chief Innovation Officer at GE and CEO of GE Ventures, will keynote the 2019 Bioelectronic Medicine Forum, which takes place in New York City on April 4, 2019. The second-annual event will be held at the Millennium Broadway Hotel & Conference Center in Times Square.

Related link: http://www.neurotechreports.com/

Magnifi Group and BESPA Global to Host Second Annual Lower Extremity IEP Fellows and Young Surgeons’ Course

SAN DIEGO, Calif. /ScoopCloud/ -- Lower Extremity Fellows, Residents and Young Surgeons from leading US Orthopaedic and Podiatric Surgery Centers and Hospitals will attend the 2nd annual Lower Extremity IEP Fellows & Young Surgeons' Course, to be held in Denver, Colo., May 3 - 5, 2019, Magnifi Group announced today.

The three-day course has been specifically developed to educate attendees on current topics pertaining to the practice of foot and ankle surgery. The course will also assist with the transition into both academic and private practice. The course draws the industry's most prestigious faculty and is directed by Gregory C. Pomeroy, MD, Clinical Associate Professor of Surgery at the University of New England. Dr. Pomeroy also serves as the Director of the Division of Foot and Ankle Surgery, St. Mary's Regional Medical Center, Portland, Maine.

"This is the premier course in the US that combines leading senior surgeons with young surgeons in practice, Fellows in foot and ankle, and senior residents who are planning to enter foot and ankle" Dr. Pomeroy said. "Last year we had 50 attendees and this year we anticipate 50 or more," Pomeroy added.

The 2019 course will begin with industry hosted cadaver labs.

"We have incorporated these labs based on feedback from last year's attendees," said Donald R. Bohay, MD, FACS, Professor Orthopaedic Surgery, Michigan State University, and IEP Program Co-Chair. "This further seals our course as the leading program for Fellows, Residents and Young Surgeons within the field of Lower Extremity," said Dr. Bohay.

Attendees will also participate in industry sessions presented by the course sponsors. Attendees will rotate through the exhibit hall in small groups, meeting and interacting with each course sponsor. Course Completion Certificates will be handed out upon conclusion of the course.

The course will be hosted at the History Colorado Museum and is exclusive to foot and ankle fellows, final year residents, and young surgeons within their first three years of practice.

For more information visit the 2019 Lower Extremity IEP Fellows and Young Surgeons' Course website at http://lowerextremity-iep.com.

About Magnifi Group:
Magnifi Group is a developer of dynamic online training solutions for leading global corporations. The company also hosts live courses for surgeons including the Spine IEP Fellows and Young Surgeons' Course and the Lower Extremity IEP Fellows and Young Surgeons' Course.

The company was founded in 2002 and has offices in San Diego, California and Wiesbaden, Germany.

About BESPA GLOBAL:
For over 13 years, BESPA USA, now known as BESPA GLOBAL has been dedicated to improving patient care through education and advancements in medical science. Their unique model is changing the way Medical Companies and Health Care Professionals work together to improve patient outcomes.

As an intermediary between Health Care Professionals and Medical Companies, BESPA GLOBAL delivers a variety of services including product development and education to medical companies and surgeons across Foot and Ankle, Plastic Surgery, Wound Healing and General Surgery.

Lower Extremity Fellows, Residents and Young Surgeons from leading US Orthopaedic and Podiatric Surgery Centers and Hospitals will attend the 2nd annual Lower Extremity IEP Fellows & Young Surgeons' Course, to be held in Denver, Colo., May 3 - 5, 2019, Magnifi Group announced today.

Related link: http://www.magnifigroup.com/

8th Annual Spine IEP Fellows and Young Surgeons’ Course Sets Record Attendance

SAN DIEGO, Calif. /ScoopCloud/ -- Magnifi Group Inc. reported a record number of Spine Fellows and Young Surgeons from top spine centers and hospitals across the U.S. in attendance at the 8th Annual Spine IEP Fellows and Young Surgeons' Course in San Francisco, Calif., on November 16-18, 2018.

The three-day course was led by Course Director, Dr. Gurvinder Deol, Chief of the Orthopaedic Spine Services at WakeMed Health and Hospitals, Raleigh, N.C.

The Fellow-Young Surgeon attendees benefited from interactive and engaging lectures, panel discussion, debates and case study presentations. Surgeon attendees also participated in several didactic sessions with a record 36 medical device companies throughout the day on Saturday, November 17.

Magnifi Group will hold its 9th Annual Spine IEP Fellows and Young Surgeons' Course November 15-17, 2019 at the Hyatt Regency Hotel in Huntington Beach, Calif. Magnifi anticipates another record-breaking year for Fellow-Young Surgeon attendees and exhibiting medical device companies.

For more information, please visit the 2019 Spine IEP Fellows and Young Surgeons' Course website at https://www.spine-iep.com/sfc/index.html.

About Magnifi Group:

Magnifi Group is a developer of dynamic online training solutions for leading global corporations. The company also hosts a live course for lower extremity surgeons - Lower Extremity IEP Fellows and Young Surgeons' Course. The company was founded in 2002 and has offices in San Diego, Calif. and Wiesbaden, Germany.

For more information, please visit https://learn-wise.com/.

Magnifi Group Inc. reported a record number of Spine Fellows and Young Surgeons from top spine centers and hospitals across the U.S. in attendance at the 8th Annual Spine IEP Fellows and Young Surgeons' Course in San Francisco, Calif., on November 16-18, 2018.

Related link: http://www.magnifigroup.com/

Magnifi Group, Inc. to Host the 8th Annual Spine IEP Fellows and Young Surgeons’ Course in San Francisco, CA

SAN DIEGO, Calif. /ScoopCloud/ -- Over 60 Spine Fellows and Young Surgeons from the United States' top spine centers and hospitals across the U.S. will attend the 8th annual Spine IEP Fellows & Young Surgeons' Course, to be held in San Francisco, Calif., November 16-18, 2018, Magnifi Group announced today.

A record 36 medical device companies will participate in the didactic sessions. Surgeon attendees will be led by a team of distinguished faculty members.

Course Director, Dr. Gurvinder Deol, Chief of the Orthopaedic Spine Service at WakeMed Health and Hospitals, Raleigh, N.C., and Clinical Assistant Professor Department of Orthopaedics UNC - Chapel Hill School of Medicine, said the three-day course has been developed specifically to educate Orthopaedic spine and neurosurgery Fellows and Young Surgeons on current topics pertaining to the practice of spine and neurosurgery.

"The course is also designed to assist Fellows with their transition from Fellowship to practice in various settings, whether academic, private, or hospital based," Dr. Deol said.

The format of the course is highly interactive - all lectures include a question and answer session and there are a number of panel discussion, debates and case study presentations over the three days. Fellows and Young Surgeons will also participate in three didactic sessions with all the course sponsors.

The invitation-only annual course will commence with a reception at 5 p.m., November 16, 2018 at the Fairmont Hotel, San Francisco.

The course draws the industry's most prestigious faculty - listed here:
* Neil Badlani, MD, MBA, The Orthopedic Sports Clinic
* Stephen Ryu, MD, Stanford University Medical Center
* Safdar N. Khan, MD, The Ohio State University
* Michael Kelly, MD, MSc, Washington University, St. Louis
* William Donaldson III, MD, University of Pittsburgh School of Medicine
* R. Todd Allen, MD, PhD, UC San Diego Health System
* Gregory Lopez, MD, Rush University Medical Center
* Daniel B. Murrey, MD, MPP, OptumCare Specialty Practices
* Gaetano J. Scuderi, MD, Jupiter Medical Center

For more information, visit the 2018 Spine IEP Fellows and Young Surgeons' Course website at https://www.spine-iep.com/sfc/index.html.

About Magnifi Group:
Magnifi Group is a developer of dynamic online training solutions for leading global corporations. The company also hosts a live course for lower extremity surgeons - Lower Extremity IEP Fellows and Young Surgeons' Course. The company was founded in 2002 and has offices in San Diego, Calif. and Wiesbaden, Germany. For more information, please visit https://learn-wise.com/.

Over 60 Spine Fellows and Young Surgeons from the United States' top spine centers and hospitals across the U.S. will attend the 8th annual Spine IEP Fellows & Young Surgeons' Course, to be held in San Francisco, Calif., November 16-18, 2018, Magnifi Group announced today.

Related link: http://www.magnifigroup.com/

Neuroprosthetics Pioneer to Keynote at the 2018 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Peckham is a Distinguished University Professor and Donnell Institute Professor of Biomedical Engineering at Case Western Reserve University. He is also associate director of technology transfer at the Cleveland FES Center and the founder of the Institute for Functional Restoration. The event will take place October 15-16 in San Francisco, Calif.

Frank Fischer, CEO of NeuroPace Inc., has also been added to the agenda as a keynote speaker. Other additions include Eddie Chang, co-director of the Center for Neural Engineering at UC Berkeley and UC San Francisco, Philip Starr, professor of neurosurgery at UCSF, Michael Ackermann, CEO of Presidio Medical, Bashar Badran from the U.S. Army Research Laboratories, Cristin Welle, a former FDA employee and now assistant professor at University of Colorado, Nick Langhals, Neural Engineering Program Manager at the National Institutes of Health, and John Donoghue, director of the Wyss Center for Neuro and Bioengineering.

Executives from several early-stage and emerging neurotech startups will also make presentations during the event. These include Manfred Franke, founder and CEO of Neuronoff Inc., Bill Edelman, chairman of Highland Instruments, Erik Nilsen, CEO of Bio-Signal Technologies, LLC, and Howard Leonhardt, CEO of CerebraCell.

The conference returns to the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif. Platinum Sponsor at this year's conference will be Cirtec Medical. Micro Systems Technologies is the Gold Sponsor. Other sponsors include IMEC, Cactus Semiconductor, Hereaus, Senso Medical, RBrooks Group, Maynard Cooper, Cleveland FES Center, along with partners the International Neuromodulation Society and Neuromodec.

"We're pleased to have such a distinguished lineup of speakers at the 2018 Neurotech Leaders Forum," said James Cavuoto, editor and publisher of Neurotech Reports. Neurotech Reports, founded in 2001, is the leading and longest-established publishing and market-research firm covering the neurotechnology industry.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/leadersforum.html.

Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Related link: http://www.neurotechreports.com/

Dr. Marchand Awarded World Record for Hysterectomy through the Smallest Incision Ever

MESA, Ariz. /ScoopCloud/ -- The World Record Academy today Awarded Dr. Greg J. Marchand, of Marchand Institute for Minimally Invasive Surgery, a world record for performing hysterectomy through the smallest incision ever. The surgery involved removal of a uterus, ovaries and Fallopian tubes all through an incision the diameter of an AAA battery. The record was awarded after a lengthy verification process performed by the academy to verify the results.

Dr. Marchand performed a hysterectomy through an 11mm incision at the bottom of the belly button using a technique called "laparoscopic single-port hysterectomy." Although laparoscopic hysterectomy has been performed through a single incision before, this is believed to be the smallest incision that it has ever been performed through. The Academy reported that the Mayo Clinic and Cleveland Clinic had reported cases through a 15mm incision, which was believed to be the previous record.

The patient, Mary Coble, provided the Academy with pictures of her belly from 4 weeks after the surgery. There was no scar visible whatsoever. Ms. Coble had suffered from debilitating pelvic pain from endometriosis and adenomyosis for years before being recommended to have the hysterectomy after other conservative treatments for her pain were unsuccessful. She assumed she would be having the hysterectomy through the same incision that she had her cesarean section went through, which was a lower abdomen horizontal incision, often referred to as the "bikini cut." She states she was surprised and delighted to find that the procedure was able to be performed through only a tiny incision in her umbilicus.

Dr. Greg Marchand, an Accredited Master Surgeon, developed this technique and led the surgical team that performed the surgery. The procedure was a modified version of a laparoscopic hysterectomy, where the only incision used is in the patient's umbilicus. "A very novel part of our technique," said Dr. Marchand, "is that because of the instrumentation we use, the incision is always going to be a reproducible 11 millimeters."

"The recovery was really easy compared to my prior laparoscopic surgeries," said Mary Coble following the procedure. Mary pointed out that she has no scars at all from the surgery, as the only tiny scar present is on the bottom of her belly button, where it is effectively invisible. Mary has previously had both laparoscopic surgery and delivered her baby by cesarean section, so she is no stranger to recovering from surgery.

"I think it's a great advancement for minimally invasive surgery." said Dr. Marchand, the lead surgeon. "When the incision shrinks from 15mm to 11mm, there are many benefits to the patient. There will be less postoperative pain, a quicker postoperative recovery, and a much lower chance of the incision causing a hernia later, which is a known complication of this type of surgery. My favorite part is that you can't even see the incision on the patient."

For media requests or more information, please contact Karen Thomas at Thomas PR at (631) 549-7575 or kthomas@thomaspr.com. Dr. Marchand is available for interview and Ms. Coble is also interested in sharing her story and interviewing for the purpose of raising awareness minimally invasive surgery and to help other women facing hysterectomy.

For more information regarding Dr. Greg Marchand, the Marchand Institute for Minimally Invasive Surgery, and their latest research publications, please visit: http://gregmarchandmd.com/.

For more information on the "Master Surgeon" Accreditation, please see the website of the Surgical Review Corporation at http://www.surgicalreview.org/.

--- Fact Sheet: ---

Date of Surgery: 07/17/2018

Date of Award of World Record Academy World Record: 08/22/2018

Actual Title of Record: "Total Hysterectomy Performed through the Smallest Incision"

Description of Technical Procedure Performed: Successful Single-port Total Laparoscopic Hysterectomy (LESS) with bilateral salpingo-oophorectomy and lysis of adhesions secondary to scar tissue from a prior cesarean section. The procedure was performed using an Olympus Tri-Port device using a modified technique through a smaller incision. The incision and abdominal entry was performed using an Ethicon 11mm blunt tip trochar in order to be sure the incision was exactly 11mm, and that the procedure was reproducible. A 5mm 30 degree laparoscope was used with wavy graspers, a bovie laparoscopic extender "hook," and a Covidien Ligasure Blunt Tipped 5mm device.

Method of Verification of Record: Direct video evidence of procedure and identifying information compared with final pathologic diagnosis by board certified pathologist. Patient consented to disclosure.

FAQ:

Can all hysterectomies be performed in this manner?

Our technique was successful in a difficult case that required dissection of scar tissue from a previous cesarean section, and also entailed scar tissue secondary to endometriosis. Unfortunately, some clinical scenarios involve worse pathology and may require a traditional laparoscopic or robotic assisted laparoscopic hysterectomy in order to be completed. We feel our technique is a valuable weapon in a surgeon's set of surgical skills but does not constitute a solution for every patient requiring a hysterectomy.

How Would Women Benefit if more Hysterectomies Were Performed Using this Technique?

With LaparoEndoscopic Single Site procedures (LESS), there is only a small scar in the area of the belly button. Because there are less incisions, the healing process is much faster and there is much less postoperative pain. In many cases patients can leave the hospital the same day as the surgery. The cosmesis is also considerably improved, with essentially no visible scars whatsoever. From a surgical perspective, you have a very complete visualization of the abdominal cavity at time of surgery, which is a big advantage for dealing with complex pathology such as endometriosis and fibroids. As a result complications are less common.

What is the invented technique?

The Marchand Institute for Minimally Invasive Surgery acknowledges prior published techniques for single port hysterectomy, also called LESS hysterectomy. There are also suggested techniques for various commercial available products developed for these surgeries. We theorized and performed a surgical technique that utilizes many of the advantages of traditional LESS surgery with an entry that utilizes a bench-marked 11mm blunt laparoscopic trochar port. The end result is a reproducible surgical technique that will continually produce a small incision in the umbilicus of exactly 11mm that is created with a blunt trochar and extremely cosmetic while also providing excellent exposure to the abdomen.

What is the Marchand Institute for Minimally Invasive Surgery, and what do they do?

The Marchand Institute for Minimally Invasive Surgery is a research and educational not-for-profit corporation and functional "Think-Tank" for the advancement of Minimally Invasive Surgery. We are located in Mesa, AZ. Our efforts are split between the publication of high-quality medical research, expert level surgical education, and involvement in clinical trials related to advancing Minimally Invasive Surgery.

Did this record involve "morcellation"?

No. Total Laparoscopic Hysterectomy generally does not require morcellation except in extreme cases, such as Dr. Marchand's 2008 Guinness World Record. For more details involving the 2008 World Record Please see: http://gregmarchandmd.com/guinness-record-marchand/

What do Dr. Marchand's accreditations mean ?

The accreditations represent honors bestowed upon Dr. Marchand by different certifying organizations. They include:

MD - Medical Doctor

FACOG - Fellow of the American College of Obstetrics and Gynecology - Certified by The American College/Congress of Obstetrics and Gynecology (acog.org)

FACS - Fellow of the American College of Surgeons - Certified by the American College of Surgeons (facs.org)

FICS - Fellow if the International College of Surgeons - Certified by The International College of Surgeons (fics.org)

Accredited Master Surgeon - Dr. Marchand is currently the only Accredited Master Surgeon in Arizona, - Certified by the Surgical Review Corporation (surgicalreview.org)

Why is this a world record? Can't a hysterectomy be done with no abdominal incision at all?

Yes, a hysterectomy can be performed vaginally without any abdominal incisions at all in uncomplicated cases without significant pathology. A completely vaginal approach, however, gives a very limited view of the abdomen and makes it difficult to deal with abdominal pathology such as scar tissue from prior surgeries and scar tissue from endometriosis. This can increase the chance of complications and injuries to surrounding organs. Using our technique we were able to directly visualize the abdominal cavity and perform the hysterectomy with less risk of complications. This was demonstrated by our ability to complete the hysterectomy safely despite this patient's history of prior cesarean sections and endometriosis. Our technique also has excellent cosmesis using only an 11mm incision that leaves essentially no scar.

How can you be sure that this is the smallest incision a laparoscopic Hysterectomy has ever been performed through? What steps did you take to verify?

We performed extensive searches of the literature in all of the relevant journals as well as PubMed. We were not able to find any reported case of total hysterectomy performed solely through this small of an incision. The World Record Academy then went on to verify the claim independently. We were awarded the record after the completion of their exhaustive verification efforts.

For media requests or more information, please contact Karen Thomas at Thomas PR at (631) 549-7575 or kthomas@thomaspr.com. Dr. Marchand is available for interview and Ms. Coble is also interested in sharing her story and interviewing for the purpose of raising awareness minimally invasive surgery and to help other women facing hysterectomy.

For more information regarding Dr. Greg Marchand, the Marchand Institute for Minimally Invasive Surgery, and their latest research publications, please visit http://gregmarchandmd.com/.

For more information on the "Master Surgeon" Accreditation, please see the website of the Surgical Review Corporation at http://www.surgicalreview.org/.

VIDEO (YouTube):
https://youtu.be/aNRxjVXECjc

The World Record Academy today Awarded Dr. Greg J. Marchand, of Marchand Institute for Minimally Invasive Surgery, a world record for performing hysterectomy through the smallest incision ever. The surgery involved removal of a uterus, ovaries and Fallopian tubes all through an incision the diameter of an AAA battery.

Related link: http://gregmarchandmd.com/